Calcimedica, Common Stock Stock Performance
| CALC Stock | 3.22 0.07 2.13% |
The firm shows a Beta (market volatility) of -0.95, which signifies possible diversification benefits within a given portfolio. As the market becomes more bullish, returns on owning CalciMedica, Common are expected to decrease slowly. On the other hand, during market turmoil, CalciMedica, Common is expected to outperform it slightly. At this point, CalciMedica, Common Stock has a negative expected return of -0.19%. Please make sure to confirm CalciMedica, Common's total risk alpha, accumulation distribution, period momentum indicator, as well as the relationship between the potential upside and day median price , to decide if CalciMedica, Common Stock performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days CalciMedica, Common Stock has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's essential indicators remain sound and the latest tumult on Wall Street may also be a sign of longer-term gains for the firm shareholders. ...more
Actual Historical Performance (%)
One Day Return (2.13) | Five Day Return 12.98 | Year To Date Return (2.13) | Ten Year Return (44.86) | All Time Return (44.86) |
Last Split Factor 1:14 | Last Split Date 2023-03-20 |
1 | Acquisition by Middleton Fred A of 13184 shares of CalciMedica, Common at 3.702 subject to Rule 16b-3 | 10/25/2024 |
2 | CalciMedica, Inc. Sees Significant Decline in Short Interest | 11/01/2024 |
3 | CalciMedica Given New 16.00 Price Target at HC Wainwright | 11/04/2024 |
4 | Insider Buying CalciMedica, Inc. Major Shareholder Acquires 86,867 Shares of Stock | 11/05/2024 |
5 | CalciMedica Strengthens Leadership Team with Appointment of Stephen Bardin as Chief Financial Officer | 11/07/2024 |
6 | Insider Trading | 11/13/2024 |
7 | Acquisition by Middleton Fred A of 4800 shares of CalciMedica, Common at 2.65 subject to Rule 16b-3 | 12/06/2024 |
8 | CalciMedica, Inc. Sees Significant Growth in Short Interest | 12/30/2024 |
| Begin Period Cash Flow | 1.5 M |
CalciMedica, |
CalciMedica, Common Relative Risk vs. Return Landscape
If you would invest 396.00 in CalciMedica, Common Stock on October 6, 2024 and sell it today you would lose (74.00) from holding CalciMedica, Common Stock or give up 18.69% of portfolio value over 90 days. CalciMedica, Common Stock is currently does not generate positive expected returns and assumes 5.454% risk (volatility on return distribution) over the 90 days horizon. In different words, 48% of stocks are less volatile than CalciMedica,, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
CalciMedica, Common Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for CalciMedica, Common's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as CalciMedica, Common Stock, and traders can use it to determine the average amount a CalciMedica, Common's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.034
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | CALC |
Estimated Market Risk
| 5.45 actual daily | 48 52% of assets are more volatile |
Expected Return
| -0.19 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.03 actual daily | 0 Most of other assets perform better |
Based on monthly moving average CalciMedica, Common is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of CalciMedica, Common by adding CalciMedica, Common to a well-diversified portfolio.
CalciMedica, Common Fundamentals Growth
CalciMedica, Stock prices reflect investors' perceptions of the future prospects and financial health of CalciMedica, Common, and CalciMedica, Common fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on CalciMedica, Stock performance.
| Return On Equity | -0.84 | ||||
| Return On Asset | -0.65 | ||||
| Current Valuation | 4.49 M | ||||
| Shares Outstanding | 13.48 M | ||||
| Price To Book | 4.81 X | ||||
| EBITDA | (34.19 M) | ||||
| Net Income | (34.36 M) | ||||
| Total Debt | 4.03 M | ||||
| Book Value Per Share | 1.42 X | ||||
| Cash Flow From Operations | (25.73 M) | ||||
| Earnings Per Share | (1.11) X | ||||
| Market Capitalization | 43.41 M | ||||
| Total Asset | 12.19 M | ||||
| Retained Earnings | (146.06 M) | ||||
| Working Capital | 7.58 M | ||||
About CalciMedica, Common Performance
By analyzing CalciMedica, Common's fundamental ratios, stakeholders can gain valuable insights into CalciMedica, Common's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if CalciMedica, Common has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if CalciMedica, Common has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | (314.81) | (330.55) | |
| Return On Tangible Assets | (3.24) | (3.08) | |
| Return On Capital Employed | (3.08) | (2.93) | |
| Return On Assets | (3.24) | (3.08) | |
| Return On Equity | (4.84) | (4.60) |
Things to note about CalciMedica, Common Stock performance evaluation
Checking the ongoing alerts about CalciMedica, Common for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for CalciMedica, Common Stock help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| CalciMedica, Common generated a negative expected return over the last 90 days | |
| CalciMedica, Common has high historical volatility and very poor performance | |
| CalciMedica, Common has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (34.36 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| CalciMedica, Common generates negative cash flow from operations | |
| CalciMedica, Common has a frail financial position based on the latest SEC disclosures | |
| About 17.0% of the company shares are held by company insiders | |
| Latest headline from thelincolnianonline.com: CalciMedica, Inc. Sees Significant Growth in Short Interest |
- Analyzing CalciMedica, Common's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether CalciMedica, Common's stock is overvalued or undervalued compared to its peers.
- Examining CalciMedica, Common's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating CalciMedica, Common's management team can have a significant impact on its success or failure. Reviewing the track record and experience of CalciMedica, Common's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of CalciMedica, Common's stock. These opinions can provide insight into CalciMedica, Common's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for CalciMedica, Stock analysis
When running CalciMedica, Common's price analysis, check to measure CalciMedica, Common's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CalciMedica, Common is operating at the current time. Most of CalciMedica, Common's value examination focuses on studying past and present price action to predict the probability of CalciMedica, Common's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CalciMedica, Common's price. Additionally, you may evaluate how the addition of CalciMedica, Common to your portfolios can decrease your overall portfolio volatility.
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation |